Obesity can have a similar impact to cancer on a child's quality of life and should be considered a long-term chronic disease, doctors said at a conference assessing the effects of the latest weight-loss drugs.
Medications such as Wegovy should form a long-term approach to beating obesity, rather than a quick fix. Pills are starting to replace injections as the next generation of fat-busting medications.
Danish pharmaceutical company Novo Nordisk launched its oral version of Wegovy β the branded injectable weight-loss drug β in the US this month.
The manufacturer of weight-loss drug Wegovy hope its oral tablet could be available soon in the UAE.
Continue Reading on The National UAE
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.